British journal of Cancer |
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. |
déc. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Hepatology |
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis |
nov. 15 |
2 ♥ |
Foie |
Clinical Gastroenterology and Hepatology |
Workplace Accommodation for Persons With IBD: What Is Needed and What Is Accessed |
oct. 17 |
2 ♥ |
MICI |
Endoscopy |
Long-term quality of life after peroral endoscopic myotomy remains compromised in patients with achalasia type III. |
déc. 17 |
2 ♥ |
Endoscopie/Imagerie |
Gastrointestinal Endoscopy |
Prognostic Variables for the Clinical Success of Flexible Endoscopic Septotomy of Zenker's Diverticulum |
sep. 15 |
2 ♥ |
Endoscopie/Imagerie, Œsophage/Estomac |
British journal of Cancer |
GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project |
juin. 17 |
2 ♥ |
Cancer colorectal (CCR) |
Gut |
Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort. |
Jan. 16 |
2 ♥ |
Endoscopie/Imagerie |
British journal of Cancer |
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
The Lancet |
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study. |
avr. 17 |
2 ♥ |
MICI |
British journal of Cancer |
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Inflammatory Bowel Diseases |
2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial |
mai. 17 |
2 ♥ |
MICI |
British journal of Cancer |
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma |
Jan. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations Open |
oct. 17 |
2 ♥ |
Cancers autres |
British journal of Cancer |
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Digestive and Liver Disease |
Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience |
avr. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Annals of oncology |
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer |
nov. 15 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of Hepatology |
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial |
mai. 16 |
2 ♥ |
Foie |
Cancer Research |
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen. |
sep. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Digestive and Liver Disease |
SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer |
Jan. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Gastrointestinal Endoscopy |
Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer |
sep. 15 |
2 ♥ |
Endoscopie/Imagerie, Cancer colorectal (CCR) |
Annals of oncology |
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomised trials |
aoû. 17 |
2 ♥ |
Cancer colorectal (CCR) |